Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04586049

Cardiovascular and Neurovascular Regulation in GWI

Brain blood flow regulation and autonomic dysfunction will be measured in Veterans with and without Gulf War Illness who served in the Gulf War between 1990 and 1992.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

45 year–68 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Wisconsin-Madison

Madison, Wisconsin, 53706, United States

About this study

Gulf War Illness (GWI) is a multi-symptom illness with unknown etiology. GWI is a leading cause of disability in Gulf War Veterans. Cognitive complaints are a common symptom of GWI, which suggests the brain is involved in the development of this condition. As Veterans age, these cognitive complaints may worsen and be compounded by the aging process. GWI may be a condition of "accelerated" brain aging. Therefore, there may be long-term consequences of GWI, and the presence of GWI may increase a person's risk for developing Alzheimer's Disease (AD) or other dementias. In comparison to other brain-related diseases such as stroke, relatively little is known about GWI and how this condition impacts the normal age-related changes in the brain.

The research aims are:

  • To determine if Veterans with Gulf War Illness demonstrate abnormal brain blood flow regulation and autonomic dysfunction when compared with Veterans without Gulf War Illness.
  • To determine if brain blood flow and autonomic nervous system variables in Veterans are associated with other markers of brain aging that are relevant to cognitive decline.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Deployed to the Persian Gulf between 1990-1992
  • Body mass <300 lbs
  • Diagnosis of Gulf War Illness based on CMI/CDC and Kansas definitions or No diagnosis of Gulf War Illness

Exclusion criteria

  • Current or lifetime evidence of: Type II diabetes, neurological disease, cancer treatment, rheumatoid arthritis, lupus, bipolar disorder, psychotic disorders, or mood disorders with psychotic features
  • Current illicit substance use or partial remission for less than 1 year
  • Taking multiple sedatives or anticonvulsant medications
  • Currently pregnant
  • Absolute contraindications to exercise testing
  • Contraindications to MRI
  • Other significant medical conditions at investigator's discretion

Treatment and study plan

MRI

Device

Participants will undergo an MRI scan while participating in a breathing test to measure brain blood flow.

Transcranial Doppler Ultrasound

Device

Participants will undergo a TCD scan while participating in a breathing test to measure brain blood flow.

Sympathetic Nerve Activity

Other

Participants will undergo sympathetic nerve activity testing while participating in a breathing test.

Primary outcomes

  1. Brain blood flow measured using Transcranial Doppler ultrasound

    Time frame: Baseline

    Neurovascular control will be investigated by measuring the change in brain blood flow using a transcranial Doppler ultrasound in response to a breathing test.

  2. Brain blood flow measured using MRI

    Time frame: Baseline

    Neurovascular control will be investigated by measuring the change in brain blood flow using an MRI in response to a breathing test.

  3. Sympathetic nerve activity

    Time frame: Baseline

    Neurovascular control will be investigated by measuring the change in sympathetic nerve activity will be measured using microneurography in response to a breathing test.

Sponsors and collaborators

Lead sponsor

University of Wisconsin, Madison

Other

Collaborators

  • United States Department of Defense

Registry information

Official study title

Autonomic Dysfunction, Brain Blood Flow and Cognitive Decline in Veterans With Gulf War Illness

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Oct 14, 2020
Registry last updated
Jun 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.